论文部分内容阅读
目的:探讨尿激酶治疗结核性胸腔积液的疗效及其可行性。方法:将110例结核性胸腔积液病人,随机分成对照组(N=56)和治疗组(N=54),采用常规抗结核疗法+强的松治疗,治疗组同时胸腔内注入尿缴酶,观察疗效。结果:治疗组胸腔积液吸收时间明显短于对照组,且无明显副作用(P<0.01)。结论:胸腔内注入尿激酶治疗结核性胸腔积液可以缩短积液吸收时间,值得临床上推广应用。
Objective: To investigate the efficacy and feasibility of urokinase in the treatment of tuberculous pleural effusion. Methods: One hundred and ten patients with tuberculous pleural effusion were randomly divided into control group (N = 56) and treatment group (N = 54), treated with conventional anti-tuberculosis therapy plus prednisone. Meanwhile, , Observe the effect. Results: The absorption time of pleural effusion in the treatment group was significantly shorter than that in the control group, with no obvious side effects (P <0.01). Conclusion: Intrapleural injection of urokinase in the treatment of tuberculous pleural effusion can shorten the time of effusion absorption, which is worth popularizing in clinic.